Katya Alves De Sousa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background Severe asthma are linked with high morbidity, significant mortality and high treatment costs. Omalizumab has been shown to decrease the risk of hospitalization or Emergency Department (ED) visits in patients with uncontrolled severe allergic asthma. We aim to describe the conditions under Omalizumab was prescribed in patients followed in a(More)
  • 1